Suchergebnisse - "Anti-viral"

PubPharm (190)

1

An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection

enthalten in: Microbiology spectrum | 2024

von Ziegler, C. | Owings, A. | Galeas-Pena, M. | +21

2

Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus

enthalten in: Virology | 2024

von Saikia, B. | Roy, K. | Konwar, R.

3

The role of ion dissolution in metal and metal oxide surface inactivation of SARS-CoV-2

enthalten in: Applied and environmental microbiology | 2024

von Hilton, J. | Nanao, Y. | Flokstra, M. | +6

4

Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza : A Perception on Combating Symptoms from COVID-19

enthalten in: Current topics in medicinal chemistry | 2024

von Man, G. | Zheng, X. | Hung, S. | +8

5

Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19

enthalten in: Irish journal of medical science | 2024

von Waseem, W. | Zafar, R. | Jan, M. | +4

6

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

enthalten in: Frontiers in pharmacology | 2024

von Maen, A. | Gok Yavuz, B. | Mohamed, Y. | +12

7

AMMI Canada Practice Point : Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023-2024

enthalten in: Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada | 2024

von Grant, J. | Lam, J. | Goyal, S. | +11

8

COVID-19 vaccination produces exercise-responsive SARS-CoV-2 specific T-cells regardless of infection history

enthalten in: Journal of sport and health science | 2024

von Smith, K. | Zúñiga, T. | Baker, F. | +6

9

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

enthalten in: Med (New York, N.Y.) | 2024

von Mao, L. | Shaabani, N. | Zhang, X. | +38

ErratumIn: Med. 2024 Feb 9;5(2):169-171. - PMID 38340710

10

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

in: Frontiers in Pharmacology | 2024

von Abdelrahim Maen | Abdelrahim Maen | Abdelrahim Maen | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]